Llovet J.M., Kelley R.K., Villanueva A., Singal A.G., Pikarsky E., Roayaie S., Lencioni R., Koike K., Zucman-Rossi J., Finn R.S. 2021. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 7 (6), 1–28. https://doi.org/10.1038/s41572-020-00240-3

Article  Google Scholar 

Sukowati C., El-Khobar K.E., Jasirwan C.O.M., Kurniawan J., Gani R.A. 2024. Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters? Ann. Hepatol. 29, 101153. https://doi.org/10.1016/j.aohep.2023.101153

Article  CAS  PubMed  Google Scholar 

Yang J.D., Hainaut P., Gores G.J., Amadou A., Plymoth A., Roberts L.R. 2019. A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16, 589–604. https://doi.org/10.1038/s41575-019-0186-y

Article  PubMed  PubMed Central  Google Scholar 

Raza A. 2014. Hepatocellular carcinoma review: Current treatment, and evidence-based medicine. World J. Gastroenterol. 20, 4115. https://doi.org/10.3748/wjg.v20.i15.4115

Article  PubMed  PubMed Central  Google Scholar 

Mansoori B., Mohammadi A., Davudian S., Shirjang S., Baradaran B. 2017. The different mechanisms of cancer drug resistance: A brief review. Adv. Pharm. Bull. 7, 339–348. https://doi.org/10.15171/apb.2017.041

Article  CAS  PubMed  PubMed Central  Google Scholar 

Juvale I.I.A., Hamid A.A.A., Halim K.B.A., Has A.T.C. 2022. P-glycoprotein: New insights into structure, physiological function, regulation and alterations in disease. Heliyon. 8, e09777. https://doi.org/10.1016/j.heliyon.2022.e09777

Article  CAS  Google Scholar 

Badiee S.A., Isu U., Khodadadi E., Moradi M. 2023. The alternating access mechanism in mammalian multidrug resistance transporters and their bacterial homologs. Membranes. 13, 568. https://doi.org/10.3390/membranes13060568

Article  CAS  PubMed  PubMed Central  Google Scholar 

Emran T.B., Shahriar A., Mahmud A.R., Rahman T., Abir M.H., Siddiquee M.F., Ahmed H., Rahman N., Nainu F., Wahyudin E., Mitra S., Dhama K., Habiballah M.M., Haque S., Islam A., Hassan M.M. 2022. Multidrug resistance in cancer: Understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front. Oncol. 12, 891652. https://doi.org/10.3389/fonc.2022.891652

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin W., Xiang D., Wang T., Zhang Y., Pham C.V., Zhou S., Jiang G., Hou Y., Zhu Y., Han Y., Qiao L., Tran P.H., Duan W. 2021. The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells. Sci. Rep. 11 (1), 10791. https://doi.org/10.1038/s41598-021-89931-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sui H., Fan Z.Z., Li Q. 2012. Signal transduction pathways and transcriptional mechanisms of ABCB1/PGP-mediated multiple drug resistance in human cancer cells. J. Int. Med. Res. 40, 426–435. https://doi.org/10.1177/147323001204000204

Article  CAS  PubMed  Google Scholar 

Ceballos M.P., Rigalli J.P., Ceré L.I., Semeñiuk M.B., Catania V.A., Ruiz M.L. 2019. ABC transporters: Regulation and association with multidrug resistance in hepatocellular carcinoma and colorectal carcinoma. Curr. Med. Chemi. 26 (7), 1224–1250. https://doi.org/10.2174/0929867325666180105103637

Article  CAS  Google Scholar 

Karthika C., Sureshkumar R., Zehravi M., Akter R., Ali F., Ramproshad S., Mondal B., Tagde P., Ahmed Z., Khan F.S., Rahman M.H., Cavalu S. 2022. Multidrug resistance of cancer cells and the vital role of P-Glycoprotein. Life. 12, 897. https://doi.org/10.3390/life12060897

Article  CAS  PubMed  PubMed Central  Google Scholar 

Springer A.D., Dowdy S.F. 2018. GalNAC-siRNA conjugates: Leading the way for delivery of RNAI therapeutics. Nucleic Acid Ther. 28 (3), 109–118. https://doi.org/10.1089/nat.2018.0736

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller C.M., Harris E.N. 2016. Antisense oligonucleotides: Treatment strategies and cellular internalization. RNA Dis. 3 (4), e1393. https://doi.org/10.14800/rd.1393

Article  CAS  PubMed  PubMed Central  Google Scholar 

Debacker A.J., Voutila J., Catley M.C., Blakey D.C., Habib N. 2020. Delivery of Oligonucleotides to the Liver with GalNAc. Mol. Ther. 28, 1759–1771. https://doi.org/10.1016/j.ymthe.2020.06.015

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui H., Zhu X., Li S., Wang P., Fang J. 2021. Liver-targeted delivery of oligonucleotides with N-acetylgalactosamine conjugation. ACS Omega. 6 (25), 16259–16265. https://doi.org/10.1021/acsomega.1c01755

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mathews D.H., Disney M.D., Childs J.L., Schroeder S.J., Zuker M., Turner D.H. 2004. Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Proc. Natl. Acad. Sci. U. S. A. 101, 7287–7292. https://doi.org/10.1073/pnas.0401799101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lorenz R., Bernhart S.H., Siederdissen C.H.Z., Tafer H., Flamm C., Stadler P.F., Hofacker I.L. 2011. ViennaRNA Package 2.0. Algorithms Mol. Biol. 6, 26. https://doi.org/10.1186/1748-7188-6-26

Article  PubMed  PubMed Central  Google Scholar 

Ding Y., Chan C.Y., Lawrence C.E. 2005. RNA secondary structure prediction by centroids in a Boltzmann weighted ensemble. RNA. 11, 1157–1166. https://rnajournal.cshlp.org/content/11/8/1157

Article  CAS  PubMed  PubMed Central  Google Scholar 

2018. MTT Stock Solution (12 mm). CSH Protocols. 2018, pdb.rec096875. https://doi.org/10.1101/pdb.rec096875

Sharma N., Arya G., Kumari R., Gupta N., Nimesh S. 2019. Evaluation of anticancer activity of silver nanoparticles on the A549 human lung carcinoma cell lines through alamar blue assay. Bio Protoc. 9 (1), e3131. https://doi.org/10.21769/bioprotoc.3131

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X., Yu S., Lou E., Tan Y.-L., Tan Z.-J. 2023. RNA 3D structure prediction: Progress and perspective. Molecules. 28, 5532. https://doi.org/10.3390/molecules28145532

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madanagopal P., Muthukumar H., Thiruvengadam K. 2022. Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains. Comput. Biol. Chem. 98, 107687. https://doi.org/10.1016/j.compbiolchem.2022.107687

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Madhagi H.A. 2024. Empowering therapeutic strategies against methicillin-resistant staphylococcus aureus riboswitch: Unveiling the potential of small molecules and antisense oligonucleotides through in silico analysis. Adv. J. Chem. Sect. A. 7 (1), 15–26. https://doi.org/10.48309/ajca.2024.413428.1405

Article  CAS  Google Scholar 

Roush W. 1997. Antisense aims for a renaissance. Science. 276, 1192–1193. https://doi.org/10.1126/science.276.5316.1192

Article  CAS  PubMed  Google Scholar 

Yoo B., Bochkareva E., Bochkarev A., Mou T.C., Gray D.M. 2004. 2’-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro. Nucleic Acids Res. 32 (6), 2008–2016. https://doi.org/10.1093/nar/gkh516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krieg A.M. 2019. Mind the gap! Nat. Biotechnol. 37, 622–623. https://doi.org/10.1038/s41587-019-0141-z

Article  CAS